Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M11,586Revenue (TTM) $M4,429Net Margin (%)13.3Altman Z-Score2.4
Enterprise Value $M18,987EPS (TTM) $0.9Operating Margin %24.2Piotroski F-Score6
P/E(ttm)26.0Beneish M-Score-2.8Pre-tax Margin (%)17.4Higher ROA y-yN
Price/Book4.210-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %27.5Current Ratio3.3Lower Leverage y-yY
Price/Free Cash Flow28.0y-y EBITDA Growth Rate %14.6ROA % (ttm)5.7Higher Current Ratio y-yY
Dividend Yield %2.1PEG0.9ROE % (ttm)16.5Less Shares Outstanding y-yY
Payout Ratio %42.0Shares Outstanding M684ROIC % (ttm)12.3Gross Margin Increase y-yN

Gurus Latest Trades with GRFS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GRFSJohn Paulson 2016-03-31 Reduce-0.72%$14.2 - $16.2
($15.14)
$ 16.9512%Reduce -29.29%17,533,764
GRFSRon Baron 2016-03-31 Add$14.2 - $16.2
($15.14)
$ 16.9512%Add 7.14%75,000
GRFSJohn Paulson 2015-12-31 Add0.7%$15.84 - $17.79
($16.9)
$ 16.950%Add 39.86%24,796,280
GRFSRon Baron 2015-12-31 Add0.01%$15.84 - $17.79
($16.9)
$ 16.950%Add 100.00%70,000
GRFSMario Gabelli 2015-12-31 Add0.01%$15.84 - $17.79
($16.9)
$ 16.950%Add 119.08%57,400
GRFSJohn Paulson 2015-09-30 Reduce-0.01%$14.75 - $16.78
($15.86)
$ 16.957%Reduce -0.52%35,458,280
GRFSRon Baron 2015-09-30 Add$14.75 - $16.78
($15.86)
$ 16.957%Add 6.06%70,000
GRFSMario Gabelli 2015-09-30 Reduce$14.75 - $16.78
($15.86)
$ 16.957%Reduce -13.25%52,400
GRFSJohn Paulson 2015-06-30 Add$15.2 - $17.43
($16.23)
$ 16.954%Add 0.11%35,642,080
GRFSRon Baron 2015-06-30 Reduce$15.2 - $17.43
($16.23)
$ 16.954%Reduce -12.70%66,000
GRFSMario Gabelli 2015-06-30 Add$15.2 - $17.43
($16.23)
$ 16.954%Add 8.37%60,400
GRFSJohn Paulson 2015-03-31 Add$15.69 - $17.78
($16.76)
$ 16.951%Add 0.05%35,603,480
GRFSMario Gabelli 2015-03-31 Add$15.69 - $17.78
($16.76)
$ 16.951%Add 16.27%55,736
GRFSJohn Paulson 2014-12-31 Reduce-0.27%$14.89 - $18.62
($17.23)
$ 16.95-2%Reduce -9.25%35,584,280
GRFSRon Baron 2014-12-31 Reduce$14.89 - $18.62
($17.23)
$ 16.95-2%Reduce -11.68%75,600
GRFSMario Gabelli 2014-12-31 Reduce$14.89 - $18.62
($17.23)
$ 16.95-2%Reduce -4.80%47,936
GRFSJohn Paulson 2014-06-30 Reduce-0.04%$18.32 - $23.22
($20.89)
$ 16.95-19%Reduce -1.06%39,210,362
GRFSMario Gabelli 2014-06-30 Reduce$18.32 - $23.22
($20.89)
$ 16.95-19%Reduce -15.45%50,354
GRFSRon Baron 2014-06-30 Reduce$18.32 - $23.22
($20.89)
$ 16.95-19%Reduce -4.37%85,600
GRFSRon Baron 2014-03-31 Add$17.46 - $21.42
($19.88)
$ 16.95-15%Add 65.77%89,514
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GRFS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GRFS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about GRFS:

    News about GRFS:

    Articles On GuruFocus.com
    John Paulson Raises Stake in Valeant, Teva Pharmaceutical Mar 18 2016 
    Gold-Focused Guru John Paulson Reports First Quarter Holdings May 22 2014 
    Is Grifols Being Overlooked? Mar 19 2014 
    John Paulson's Top Five Holdings Nov 20 2013 
    John Paulson's Top Five Holdings Sep 12 2013 
    Baron Funds Comments on Grifols SA Aug 30 2012 
    Friday Value Overview Aug 19 2011 

    More From Other Websites
    Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12,... Jul 12 2016
    Pedigri®: the tool that increases the information transparency to the plasma-derived manufactured... Jul 05 2016
    ETF’s with exposure to Grifols SA : June 30, 2016 Jun 30 2016
    Award Winners of the 9th Annual Martín Villar Haemostasis Awards Jun 30 2016
    Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : June 29,... Jun 29 2016
    Award Winner of the 2016 SPIN Awards Program Jun 29 2016
    Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 : By the numbers : June 23, 2016 Jun 22 2016
    Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 Jun 22 2016
    FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood... Jun 21 2016
    Zika Blood Screening Test From Hologic, Grifols Gets FDA Nod Jun 20 2016
    Hologic And Grifols Get FDA Approval For Procleix Zika Virus Assay Jun 20 2016
    FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood... Jun 20 2016
    Analyzing IBB’s Moving Averages Jun 16 2016
    Grifols confirms that it has voluntarily signed the EFPIA Code of Conduct Jun 16 2016
    Grifols Maintains Its Dividend Payout at 40% Jun 01 2016
    Singulex announces a $50 million investment by Grifols for a 20% stake in the company May 31 2016
    Grifols allocates EUR 213 million to dividends and maintains pay-out at 40% of consolidated net... May 27 2016
    Grifols allocates EUR 213 million to dividends and maintains pay-out at 40% of consolidated net... May 27 2016
    5 Big Dividend Stocks Billionaire John Paulson Loves May 23 2016
    Grifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the... May 05 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)